High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects

BACKGROUND: PARP-1 plays a critical role in DNA damage repair and contributes to progression of cancer. To explore the role of PARP-1 in acute myeloid leukemia (AML), we analyzed the expression of PARP-1 in AML and its relation to the clinical prognosis. Then, we investigated the efficacy and mechan...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:EBioMedicine
Huvudupphovsmän: Li, Xia, Li, Chenying, Jin, Jingrui, Wang, Jinghan, Huang, Jiansong, Ma, Zhixin, Huang, Xin, He, Xiao, Zhou, Yile, Xu, Yu, Yu, Mengxia, Huang, Shujuan, Yan, Xiao, Li, Fenglin, Pan, Jiajia, Wang, Yungui, Yu, Yongping, Jin, Jie
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2018
Ämnen:
Research paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6306376/
https://ncbi.nlm.nih.gov/pubmed/30472087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.11.025
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk